• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

Comprehensive Overview of 6-(2-Aminoethyl)-1-methyl-1H-indazole (CAS No. 1159511-56-4)

6-(2-Aminoethyl)-1-methyl-1H-indazole (CAS No. 1159511-56-4) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its unique indazole core and aminoethyl side chain, is widely studied for its potential applications in drug discovery and development. Researchers are particularly interested in its structural properties, which make it a promising candidate for modulating biological pathways.

The molecular structure of 6-(2-Aminoethyl)-1-methyl-1H-indazole includes a 1-methyl-1H-indazole scaffold, a heterocyclic framework known for its versatility in medicinal chemistry. The addition of a 2-aminoethyl group enhances its reactivity and binding affinity, making it valuable for targeting specific receptors or enzymes. This compound is often explored in the context of central nervous system (CNS) research, where its potential interactions with neurotransmitter systems are of particular interest.

In recent years, the demand for 6-(2-Aminoethyl)-1-methyl-1H-indazole has increased due to its relevance in high-throughput screening and structure-activity relationship (SAR) studies. Its CAS No. 1159511-56-4 is frequently searched in academic and industrial databases, reflecting its importance in modern drug design. Scientists are also investigating its role in neuroprotection and cognitive enhancement, aligning with current trends in neurodegenerative disease research.

One of the key advantages of 6-(2-Aminoethyl)-1-methyl-1H-indazole is its synthetic accessibility, which allows for efficient modification and optimization. Researchers often employ solid-phase synthesis or microwave-assisted reactions to produce derivatives with improved pharmacokinetic properties. The compound's logP and solubility profiles are also critical factors in its development as a potential therapeutic agent.

From an analytical perspective, 6-(2-Aminoethyl)-1-methyl-1H-indazole is typically characterized using techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and high-performance liquid chromatography (HPLC). These methods ensure purity and confirm structural integrity, which are essential for reliable experimental results. The compound's stability under various conditions is another area of active investigation, particularly for long-term storage and formulation studies.

The growing interest in 6-(2-Aminoethyl)-1-methyl-1H-indazole is also driven by its potential applications in precision medicine and personalized therapeutics. As the field moves toward tailored treatments, compounds with well-defined mechanisms of action, like this one, are increasingly valuable. Its compatibility with bioisosteric replacement strategies further expands its utility in drug design.

In summary, 6-(2-Aminoethyl)-1-methyl-1H-indazole (CAS No. 1159511-56-4) represents a compelling subject of study in contemporary medicinal chemistry. Its structural features, synthetic flexibility, and biological relevance make it a focal point for researchers aiming to address unmet medical needs. As scientific advancements continue, this compound is likely to play a pivotal role in the development of next-generation therapeutics.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)